Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 8/2025

Content (38 Articles)

Assessment of compartment-specific CD103-positive cells for prognosis prediction of colorectal cancer

Anpei Huang, Yuanhui Wu, Ji Cui, Muyan Cai, Yumo Xie, Jialin Zou, Maram Alenzi, Hui Yang, Pinzhu Huang, Meijin Huang

Characteristics and outcomes of primary and secondary resistance to immune checkpoint inhibitors in hepatocellular carcinoma

Xiaowen Cui, Minghao Ruan, Yao Li, Cheng Yang, Jin Zhang, Riming Jin, Dong Wu, Wen Sun, Ruoyu Wang

Glutamate transporter SLC1A6 promotes resistance to immunotherapy in cancer

Chenchen Li, Yi Lin, Haoran Zheng, Hengda Zeng, Longhao Xu, Daqin Wu, Jianwen Lao, Peicong Cai, Shuai Liang, Chunhui Wang, Tianxin Lin, Wenlong Zhong

Clinical efficacy and biomarkers of neoadjuvant chemoimmunotherapy in locally advanced esophageal squamous cell carcinoma

Siyou Deng, Qi Wang, Yueping Li, Ruijie Zhang, Jinjie Li, Yujie Zhang, Yixin Cai, Wei Sun, Jiang Chang, Ni Zhang, Li Zhang

Clinical factors associated with growth and neoantigen reactivity of tumor infiltrating lymphocytes from metastatic epithelial cancers

  • Open Access
  • Research

Alexandra M. Gustafson, Aaron J. Dinerman, Kyle J. Hitscherich, Maria R. Parkhurst, Hyunmi Halas, Donald E. White, Chuong D. Hoang, Jonathan M. Hernandez, Mei Li M. Kwong, Nicholas D. Klemen, Steven A. Rosenberg, Stephanie L. Goff, James C. Yang

Tertiary lymphoid structures in the microenvironment of colorectal cancer: exploring new therapeutic targets

Nan-Nan Dai, Man-Yi Hu, Jian-Ping Wang, Zhi-Hui Dai, Li Xu, Tai-Wei Ye

Immunological synapse formation as a key mechanism in T cell-dependent bispecific antibody-mediated immune activation and cytotoxicity

Rikuto Nakamura, Ryo Tsumura, Takahiro Anzai, Ryutaro Asano, Masahiro Yasunaga

Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic cancer

Nilesh U. Deshpande, Anna Bianchi, Haleh Amirian, Iago De Castro Silva, Christine I. Rafie, Bapurao Surnar, Karthik Rajkumar, Akash Ashokan, Ifeanyichukwu C. Ogobuiro, Manan Patel, Erietta Stelekati, Shanta Dhar, Jashodeep Datta

Correction: KLF12 as a potential biomarker for lateral pelvic lymph node metastases in advanced rectal cancer

Tixian Xiao, Fangze Wei, Sicheng Zhou, Fuqiang Zhao, Fei Huang, Liu Qian

Intratumoral IL12 mRNA administration activates innate and adaptive pathways in checkpoint inhibitor-resistant tumors resulting in complete responses

Jayalakshmi Lakshmipathi, Sreevidya Santha, Man Li, Yuping Qian, Simon F. Roy, Nadia Luheshi, Katerina Politi, Marcus Bosenberg, Jim Eyles, Viswanathan Muthusamy

Tumor-promoting function of paternally expressed gene 10 and its immunogenicity in inducing anti-tumor helper T cells in head and neck squamous cell carcinoma

  • Open Access
  • Research

Hiroki Komatsuda, Toshihiro Nagato, Akemi Kosaka, Takayuki Ohkuri, Takaaki Sasaki, Takumi Kumai, Michihisa Kono, Hidekiyo Yamaki, Risa Wakisaka, Shunsuke Yasuda, Takahiro Inoue, Ryusuke Hayashi, Nanami Ujiie, Ryosuke Sato, Kenzo Ohara, Kan Kishibe, Tatsuya Hayashi, Miki Takahara, Hiroya Kobayashi

T cell-derived small extracellular vesicles in cancer–immune interactions

  • Open Access
  • Review

Ma Janelle Chichoco Garcia, Su Su Thae Hnit, Elena Shklovskaya, Yuling Wang

Dissecting response to neoadjuvant immunotherapy-treated melanoma using cancer-immunity cycle-associated signatures

S. C. M. A. Wijnen, P. Dimitriadis, I. L. M. Reijers, A. M. Menzies, G. V. Long, L. F. A. Wessels, C. U. Blank

Simultaneous TGF-β and GITR pathway modulation promotes anti-tumor immunity in glioma

Daniela Lorizio, Manuela Silginer, Julia Friesen, Alan L. Epstein, Michael Weller, Patrick Roth

Diversity of mast cell subpopulations in the tumor microenvironment of colorectal cancer and their prognostic implications

Tianyu Qiao, Chao Ding, Songtao Yu, Wenyang Li, Yonghou Zhao, Guiyu Wang

Salvianic acid A enhances anti-PD-1 therapy by promoting HEV-mediated stem-like CD8 T cells infiltration in TNBC

Xiaoming Ding, Gai Liang, Yan Luo, Xiaomei Zhou, Qu Zhang, Bo Luo

TCR-based cellular immunotherapy for hepatocellular carcinoma: advances, challenges, and prospects

Wanting Zeng, Wei Zhu, Guosheng Yuan, Jinzhang Chen, Zhanhui Wang, Jinlin Hou, De-Ke Jiang

Divergent therapeutic and prognostic impacts of immunogenic features in undifferentiated pleomorphic sarcoma and myxofibrosarcoma

Siddh van Oost, Debora M. Meijer, Zeynep B. Erdem, Marieke E. IJsselsteijn, Jessica Roelands, Suk Wai Lam, Melissa S. Boejharat, Brendy E. W. M. van den Akker, Ruud van der Breggen, Inge H. Briare-de Bruijn, Lukas J. A. C. Hawinkels, Anouk A. Kruiswijk, Manon van der Ploeg, Pauline M. Wijers-Koster, Rick L. Haas, Michiel A. J. van den Sande, Noel F. C. C. de Miranda, Judith V. M. G. Bovee

Favorable impact of zanubrutinib combined with R-CHOP regimen in MYD88-mutated new-diagnosed diffuse large B-cell lymphoma: a retrospective study with propensity score-matched analysis

Xiubin Xiao, Shunzong Yuan, Xilin Chen, Xia Liu, Ruiqing Zhao, Shihua Zhao, Yun Lu, Yi Ma, Junli Chen, Yueqi Wang, Nana Cheng, Hua Yin, Honghao Gao, Pan Feng, Wenrong Huang

Clinical outcomes following PD-1 inhibitor elective discontinuation in cutaneous squamous cell carcinoma: exploring treatment de-escalation

Itamar Averbuch, Nofar Edri, Nethanel Asher, Gal Markel, Daniel Hendler, Hadas Ditzian Kugler, Eyal Yosefof, Noga Kurman

Pre-clinical safety and efficacy evaluation of Helicobacter Pylori neutrophil-activating protein (NAP)-armed CAR-T cells targeting B cell lymphomas

Jing Ma, Tina Sarén, Chuan Jin, Hyeong Su Kim, Paola Donaji Contreras Pineda, Marina de Bernard, Rose-Marie Amini, Veronica Rondahl, Gunilla Enblad, Di Yu, Magnus Essand

Correlation between T cell immunity and the duration of EGFR-TKI resistance acquisition in patients harboring EGFR mutations

Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Ayako Shiono, Yu Miura, Kosuke Hashimoto, Satoshi Yamasaki, Fuyumi Nishihara, Hisao Imai, Kunihiko Kobayashi, Hiroshi Kagamu

Real-world effectiveness and safety of first-line chemoimmunotherapy combinations in metastatic non-small cell lung cancer with programmed death ligand-1 < 50%: results from an Italian observational study

Alessandro Inno, Antonello Veccia, Ettore D’Argento, Floriana Morgillo, Elio Gregory Pizzutilo, Fabiana Vitiello, Alberto Pavan, Fiorella Lombardo, Marco Russano, Vincenzo Sforza, Francesca Colamartini, Carlo Genova, Rita Chiari, Antonella Cristofano, Alessandro Delconte, Emanuela Vattemi, Alessandra Dessi, Daniele Galanti, Simona Busato, Giovanni Palazzolo, Clementina Savastano, Antonio Bianco, Francesco Verderame, Cristina Mazzi, Fabiana Marchetti, Stefania Kinspergher, Denis Occhipinti, Carminia Maria Della Corte, Daniele Piscazzi, Marina Gilli, Emilio Bria, Orazio Caffo, Stefania Gori

Single-cell RNA sequencing and multi-omics analysis of prognosis-related staging in papillary thyroid cancer

Guo Ji, Hanlin Sun, Simo Chen, Xuechen Sun, Le Chang, Ruting Xie, Runzhi Huang, Lijun Zheng, Zhengyan Chang

TGF-β3 promotes vascular normalization of prostate cancer to potentiate immunotherapy and chemotherapy

Qiliang Teng, Niu Wang, Hanqi Lei, Tongyu Tong, Yupeng Guan, Mengjun Huang, Fei Cao, Bin Xu, Jia Yang, Yimian Huo, Wenping Chen, Ran Bi, Xuanqi Wang, Zhenyu Wang, Fu-Ying Tian, Bo Zhao, Jun Pang

Comprehensive analysis of exosome-related gene signature in multiple myeloma prognosis and immune microenvironment evaluation

Dong Zheng, Bingxin Zhang, Quanqiang Wang, Sisi Zheng, Yibo Xia, Ziwei Zheng, Zhili Lin, Shuxia Zhu, Xinyi Zhang, Luning Cui, Hansen Ying, Tianyu Zhang, Shujuan Zhou, Zixing Chen, Enqing Lan, Yu Zhang, Xuanru Lin, Jingjing Chen, Honglan Qian, Xudong Hu, Yan Zhuang, Zuoting Xie, Xiangjing Zhou, Zhouxiang Jin, Songfu Jiang, Yongyong Ma

Concurrent treatment with transarterial immunoembolization of hepatic metastases and systemic immune checkpoint inhibitors to overcome immune evasion in patients with metastatic uveal melanoma

Natalie J. Miller, Sharon W. Kwan, Jacob B. Leary, Daniel S. Hippe, William McCamy, Joshua R. Veatch, Evan T. Hall, Wayne L. Monsky, Shailender Bhatia

Local–regional therapy combined with immune checkpoint inhibitors and lenvatinib versus immune checkpoint inhibitors plus chemotherapy in advanced intrahepatic cholangiocarcinoma: a multicenter cohort study

Shuofeng Li, Guanhua Yu, Mingming Wang, Shi Feng, An Zhang, Yu Wu, Zixiang Zhou, Shanshan Wang, Yihong Zhang, Mingjian Piao, Chengjie Li, Ziyu Xun, Boyu Sun, Jiongyuan Li, Nan Zhang, Hu Li, Yongliang Sun, Wen Zhang, Zhenyu Zhu, Haitao Zhao

Anti-TIGIT therapies: a review of preclinical and clinical efficacy and mechanisms

Erin C. Sundstrom, Xueting Huang, Andrew J. Wiemer

Is adjuvant immunotherapy necessary after neoadjuvant chemoimmunotherapy in patients with resectable stage III NSCLC? A two-center real-world study

  • Open Access
  • NSCLC
  • Research

Song Guan, Hui Wang, Zhaoxin Chen, Fengrui Guo, Guozhen Yi, Xingyu Du, Jingjing Yan, Cuimeng Tian

A multifunctional T-cell engager containing CD80 enhances prostate cancer treatment

Disen Nie, Yao Jiang, Hui Li, Keying Zhang, Zhengxuan Li, Tong Lu, Yu Li, Donghui Han, Changhong Shi, Nianzeng Xing, Fa Yang, Weihong Wen, Weijun Qin

Keynote webinar | Spotlight on progress in colorectal cancer

On-demand video coming soon

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Prof. Antoni Castells
Prof. Harpreet Wasan
Prof. Edward Giovannucci
Notify me
Image Credits
Colon cancer illustration/© (M) KATERYNA KON / SCIENCE PHOTO LIBRARY / Getty Images